{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T23:24:49Z","timestamp":1792193089790,"version":"4.4.0"},"reference-count":39,"publisher":"Wiley","issue":"3","license":[{"start":{"date-parts":[[2011,11,18]],"date-time":"2011-11-18T00:00:00Z","timestamp":1321574400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Basic Clin Pharma Tox"],"published-print":{"date-parts":[[2012,3]]},"abstract":"<jats:p><jats:bold>Abstract:\u2002<\/jats:bold>The hybrid created from the crossbreeding of European and African bees, known as the Africanised bee, has provided numerous advantages for current beekeeping. However, this new species exhibits undesirable behaviours, such as colony defence instinct and a propensity to attack<jats:italic>en masse<\/jats:italic>, which can result in serious accidents. To date, there is no effective treatment for cases of Africanised bee envenomation. One promising technique for developing an efficient antivenom is the use of phage display technology, which enables the production of human antibodies, thus avoiding the complications of serum therapy, such as anaphylaxis and serum sickness. The aim of this study was to produce human monoclonal single\u2010chain Fv (scFv) antibody fragments capable of inhibiting the toxic effects of Africanised bee venom. We conducted four rounds of selection of antibodies against the venom and three rounds of selection of antibodies against purified melittin. Three clones were selected and tested by enzyme\u2010linked immunosorbent assay to verify their specificity for melittin and phospholipase A2. Two clones (C5 and C12) were specific for melittin, and one (A7) was specific for phospholipase A2. In a kinetic haemolytic assay, these clones were evaluated individually and in pairs. The A7\u2013C12 combination had the best synergistic effect and was chosen to be used in the assays of myotoxicity inhibition and lethality. The A7\u2013C12 combination inhibited the<jats:italic>in vivo<\/jats:italic>myotoxic effect of the venom and increased the survival of treated animals.<\/jats:p>","DOI":"10.1111\/j.1742-7843.2011.00821.x","type":"journal-article","created":{"date-parts":[[2011,10,21]],"date-time":"2011-10-21T12:06:20Z","timestamp":1319198780000},"page":"290-297","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":37,"title":["Production of Human Antibody Fragments Binding to Melittin and Phospholipase A2 in Africanised Bee Venom: Minimising Venom Toxicity"],"prefix":"10.1111","volume":"110","author":[{"given":"Jaqueline C.","family":"Funayama","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manuela B.","family":"Pucca","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eduardo C.","family":"Roncolato","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tha\u00eds B.","family":"Bertolini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lucas B.","family":"Campos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jos\u00e9 E.","family":"Barbosa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2011,11,18]]},"reference":[{"key":"e_1_2_7_2_2","volume-title":"Manual de diagn\u00f3stico e tratamento de acidentes por animais pe\u00e7onhentos","author":"FUNASA, FNdS","year":"2001"},{"key":"e_1_2_7_3_2","doi-asserted-by":"publisher","DOI":"10.4269\/ajtmh.1999.61.361"},{"key":"e_1_2_7_4_2","doi-asserted-by":"publisher","DOI":"10.1007\/s00467-002-0888-0"},{"key":"e_1_2_7_5_2","doi-asserted-by":"publisher","DOI":"10.1590\/S0102-311X2006000200018"},{"key":"e_1_2_7_6_2","unstructured":"Centro de Vigil\u00e2ncia Epidemiol\u00f3gica DdZ CVE.Acidentes por animais pe\u00e7onhentos. [updated 2011].http:\/\/www.cve.saude.sp.gov.br\/htm\/cve_peconhentos.html.2011(last accessed on 19 January 2011)."},{"key":"e_1_2_7_7_2","doi-asserted-by":"crossref","DOI":"10.1016\/B978-0-12-554770-3.50011-5","volume-title":"Chemistry and Pharmacology of Honey Bee Venom","author":"Banks BEC","year":"1986"},{"key":"e_1_2_7_8_2","doi-asserted-by":"publisher","DOI":"10.1007\/s000110300026"},{"key":"e_1_2_7_9_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0006-3495(81)84719-4"},{"key":"e_1_2_7_10_2","volume-title":"Animal Toxins: State of the Art","author":"De Lima MH","year":"2009"},{"key":"e_1_2_7_11_2","doi-asserted-by":"publisher","DOI":"10.1126\/science.177.4046.314"},{"key":"e_1_2_7_12_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.colsurfb.2009.06.006"},{"key":"e_1_2_7_13_2","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1016\/S0022-3565(25)11242-1","article-title":"Effects of the amphiphilic peptides melittin and mastoparan on calcium influx, phosphoinositide breakdown and arachidonic acid release in rat pheochromocytoma PC12 cells","volume":"260","author":"Choi OH","year":"1992","journal-title":"J Pharmacol Exp Ther"},{"key":"e_1_2_7_14_2","doi-asserted-by":"publisher","DOI":"10.1007\/BF00251045"},{"key":"e_1_2_7_15_2","doi-asserted-by":"publisher","DOI":"10.1016\/0006-2952(69)90167-1"},{"key":"e_1_2_7_16_2","doi-asserted-by":"publisher","DOI":"10.1016\/0006-2952(86)90438-7"},{"key":"e_1_2_7_17_2","first-page":"215","article-title":"Poisoning by bee sting","volume":"141","author":"de Roodt AR","year":"2005","journal-title":"Gac Med Mex"},{"key":"e_1_2_7_18_2","doi-asserted-by":"publisher","DOI":"10.1590\/S0037-86822000000400012"},{"key":"e_1_2_7_19_2","doi-asserted-by":"publisher","DOI":"10.1021\/bp030070k"},{"key":"e_1_2_7_20_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbagen.2006.04.008"},{"key":"e_1_2_7_21_2","doi-asserted-by":"publisher","DOI":"10.1016\/0022-2836(91)90498-U"},{"key":"e_1_2_7_22_2","volume-title":"The QIAexpressionist \u2013 A Handbook for High\u2010Level Expression and Purification of 6xHis\u2010Tagged Proteins","author":"QIAGEN","year":"2003"},{"key":"e_1_2_7_23_2","unstructured":"KarberC.Karber\u2019s Method of Determining LD50.BurnJH(ed.).Oxford University Press London 1937;37\u201340."},{"key":"e_1_2_7_24_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaci.2008.01.047"},{"key":"e_1_2_7_25_2","first-page":"99","article-title":"Poisoning syndrome due to 2,000 stings of africanized honeybees","volume":"18","author":"Azevedo RV","year":"2006","journal-title":"Rev bras ter intensiva"},{"key":"e_1_2_7_26_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1742-7843.2008.00322.x"},{"key":"e_1_2_7_27_2","doi-asserted-by":"publisher","DOI":"10.1007\/s10540-006-9030-z"},{"key":"e_1_2_7_28_2","volume-title":"An\u00e1lise conformacional da melitina por din\u00e2mica molecular e caracteriza\u00e7\u00e3o dos efeitos do pept\u00eddeo na fun\u00e7\u00e3o plaquet\u00e1ria","author":"Terra MRS","year":"2006"},{"key":"e_1_2_7_29_2","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M805171200"},{"key":"e_1_2_7_30_2","doi-asserted-by":"publisher","DOI":"10.3109\/08860229809045088"},{"key":"e_1_2_7_31_2","doi-asserted-by":"publisher","DOI":"10.1542\/peds.2005-1075"},{"key":"e_1_2_7_32_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.toxicon.2006.04.016"},{"key":"e_1_2_7_33_2","first-page":"209","article-title":"Acute renal failure following bee stings: case reports","volume":"42","author":"Daher Ede F","year":"2009","journal-title":"Rev Soc Bras Med Trop"},{"key":"e_1_2_7_34_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1740-8261.2005.00054.x"},{"key":"e_1_2_7_35_2","first-page":"541","article-title":"What physicians should know about Africanized honeybees","volume":"163","author":"Sherman RA","year":"1995","journal-title":"West J Med"},{"key":"e_1_2_7_36_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajem.2007.02.046"},{"key":"e_1_2_7_37_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijcard.2008.01.050"},{"key":"e_1_2_7_38_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijcard.2008.04.086"},{"key":"e_1_2_7_39_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1432-1327.2001.01923.x"},{"key":"e_1_2_7_40_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jmb.2004.12.060"}],"container-title":["Basic &amp; Clinical Pharmacology &amp; Toxicology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1742-7843.2011.00821.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1742-7843.2011.00821.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,13]],"date-time":"2025-03-13T04:39:38Z","timestamp":1741840778000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1742-7843.2011.00821.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,11,18]]},"references-count":39,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2012,3]]}},"alternative-id":["10.1111\/j.1742-7843.2011.00821.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1742-7843.2011.00821.x","archive":["Portico"],"relation":{},"ISSN":["1742-7835","1742-7843"],"issn-type":[{"value":"1742-7835","type":"print"},{"value":"1742-7843","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,11,18]]},"assertion":[{"value":"2011-11-18","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}